Regeneron· @Regeneron · X·· 1 天前AI 评分42
AI 导读
我们研究性双特异性抗体在低级别浆液性#卵巢癌（#LGSOC）中取得积极的初步结果，坚定了我们为难以治疗癌症患者推进治疗的愿景。 了解更多关于最新突破性结果：https://bit.ly/4AKnNcT #IGCS2026
正文
Positive preliminary results for our investigational bispecific antibody in low-grade serous #OvarianCancer (#LGSOC) reinforce our vision to advance care for people with difficult-to-treat cancers.
Learn more about the late-breaking results: https://bit.ly/4AKnNcT
#IGCS2026
来源：Regeneron · x.com